99 related articles for article (PubMed ID: 8741990)
1. Purification of subunit B of Shiga toxin using a synthetic trisaccharide-based affinity matrix.
Pozsgay V; Trinh L; Shiloach J; Robbins JB; Donohue-Rolfe A; Calderwood SB
Bioconjug Chem; 1996; 7(1):45-55. PubMed ID: 8741990
[TBL] [Abstract][Full Text] [Related]
2. Recognition of human milk oligosaccharides by bacterial exotoxins.
El-Hawiet A; Kitova EN; Klassen JS
Glycobiology; 2015 Aug; 25(8):845-54. PubMed ID: 25941008
[TBL] [Abstract][Full Text] [Related]
3. One step high yield affinity purification of shiga-like toxin II variants and quantitation using enzyme linked immunosorbent assays.
Acheson DW; Jacewicz M; Kane AV; Donohue-Rolfe A; Keusch GT
Microb Pathog; 1993 Jan; 14(1):57-66. PubMed ID: 8321118
[TBL] [Abstract][Full Text] [Related]
4. Purification and crystallization of Shiga toxin from Shigella dysenteriae.
Kozlov YV; Chernaia MM; Fraser ME; James MN
J Mol Biol; 1993 Jul; 232(2):704-6. PubMed ID: 8345529
[TBL] [Abstract][Full Text] [Related]
5. Structure of the shiga-like toxin I B-pentamer complexed with an analogue of its receptor Gb3.
Ling H; Boodhoo A; Hazes B; Cummings MD; Armstrong GD; Brunton JL; Read RJ
Biochemistry; 1998 Feb; 37(7):1777-88. PubMed ID: 9485303
[TBL] [Abstract][Full Text] [Related]
6. Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands.
Kitov PI; Sadowska JM; Mulvey G; Armstrong GD; Ling H; Pannu NS; Read RJ; Bundle DR
Nature; 2000 Feb; 403(6770):669-72. PubMed ID: 10688205
[TBL] [Abstract][Full Text] [Related]
7. Purification of Shiga toxin by alpha-D-galactose-(1----4)-beta-D-galactose-(1----4)-beta-D-glucose-(1- ---) receptor ligand-based chromatography.
Ryd M; Alfredsson H; Blomberg L; Andersson A; Lindberg AA
FEBS Lett; 1989 Dec; 258(2):320-2. PubMed ID: 2689221
[TBL] [Abstract][Full Text] [Related]
8. Solution structure of the complex between the B-subunit homopentamer of verotoxin VT-1 from Escherichia coli and the trisaccharide moiety of globotriaosylceramide.
Shimizu H; Field RA; Homans SW; Donohue-Rolfe A
Biochemistry; 1998 Aug; 37(31):11078-82. PubMed ID: 9693003
[TBL] [Abstract][Full Text] [Related]
9. Purification of Shiga toxin and Shiga-like toxins I and II by receptor analog affinity chromatography with immobilized P1 glycoprotein and production of cross-reactive monoclonal antibodies.
Donohue-Rolfe A; Acheson DW; Kane AV; Keusch GT
Infect Immun; 1989 Dec; 57(12):3888-93. PubMed ID: 2807552
[TBL] [Abstract][Full Text] [Related]
10. Binding of avian ovomucoid to shiga-like toxin type 1 and its utilization for receptor analog affinity chromatography.
Miyake M; Utsuno E; Noda M
Anal Biochem; 2000 Jun; 281(2):202-8. PubMed ID: 10870836
[TBL] [Abstract][Full Text] [Related]
11. Single-step method for purification of Shiga toxin-1 B subunit using receptor-mediated affinity chromatography by globotriaosylceramide-conjugated octyl sepharose CL-4B.
Nakajima H; Katagiri YU; Kiyokawa N; Taguchi T; Suzuki T; Sekino T; Mimori K; Saito M; Nakao H; Takeda T; Fujimoto J
Protein Expr Purif; 2001 Jul; 22(2):267-75. PubMed ID: 11437603
[TBL] [Abstract][Full Text] [Related]
12. Affinities of Shiga toxins 1 and 2 for univalent and oligovalent Pk-trisaccharide analogs measured by electrospray ionization mass spectrometry.
Kitova EN; Kitov PI; Paszkiewicz E; Kim J; Mulvey GL; Armstrong GD; Bundle DR; Klassen JS
Glycobiology; 2007 Oct; 17(10):1127-37. PubMed ID: 17686801
[TBL] [Abstract][Full Text] [Related]
13. Large-scale chemical and chemo-enzymatic synthesis of a spacer-containing Pk-trisaccharide.
Kamath VP; Yeske RE; Gregson JM; Ratcliffe RM; Fang YR; Palcic MM
Carbohydr Res; 2004 Apr; 339(6):1141-6. PubMed ID: 15063203
[TBL] [Abstract][Full Text] [Related]
14. A system for production and rapid purification of large amounts of the Shiga toxin/Shiga-like toxin I B subunit.
Calderwood SB; Acheson DW; Goldberg MB; Boyko SA; Donohue-Rolfe A
Infect Immun; 1990 Sep; 58(9):2977-82. PubMed ID: 2201641
[TBL] [Abstract][Full Text] [Related]
15. Shiga toxin: purification, structure, and function.
Donohue-Rolfe A; Acheson DW; Keusch GT
Rev Infect Dis; 1991; 13 Suppl 4():S293-7. PubMed ID: 2047652
[TBL] [Abstract][Full Text] [Related]
16. A method for the purification of Shiga-like toxin 1 subunit B using a commercially available galabiose-agarose resin.
Tarragó-Trani MT; Storrie B
Protein Expr Purif; 2004 Dec; 38(2):170-6. PubMed ID: 15555932
[TBL] [Abstract][Full Text] [Related]
17. Modified blood group A trisaccharide probes: synthesis and interaction with antibodies.
Shipova EV; Bovin NV
Carbohydr Lett; 2001; 4(2):85-90. PubMed ID: 11506162
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of a core trisaccharide as a versatile building block for N-glycans and glycoconjugates.
Unverzagt C
Chemistry; 2003 Mar; 9(6):1369-76. PubMed ID: 12645026
[TBL] [Abstract][Full Text] [Related]
19. An entropically efficient supramolecular inhibition strategy for Shiga toxins.
Kitov PI; Lipinski T; Paszkiewicz E; Solomon D; Sadowska JM; Grant GA; Mulvey GL; Kitova EN; Klassen JS; Armstrong GD; Bundle DR
Angew Chem Int Ed Engl; 2008; 47(4):672-6. PubMed ID: 18098248
[No Abstract] [Full Text] [Related]
20. Assessing carbohydrate-carbohydrate interactions by NMR spectroscopy: the trisaccharide epitope from the marine sponge Microciona prolifera.
Santos JI; Carvalho de Souza A; Cañada FJ; Martín-Santamaría S; Kamerling JP; Jiménez-Barbero J
Chembiochem; 2009 Feb; 10(3):511-9. PubMed ID: 19123195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
